Yeo Miji, El-Mallah Jessica C, Horchler Summer N, Waldron Olivia, Asgardoon Mohammad Hossein, Jikaria Neekita R, Dawes Jazzmyn, Landmesser Mary, Sun Mingjie, Ozbolat Ibrahim T, Ravnic Dino J
Engineering Science and Mechanics, Pennsylvania State University, University Park, PA, USA; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
Penn State Hershey Medical Center, Department of Surgery, Hershey, PA, USA; Penn State, College of Medicine, Hershey, PA, USA.
Biomaterials. 2025 Sep 13;326:123711. doi: 10.1016/j.biomaterials.2025.123711.
Intraoperative bioprinting (IOB) is an advanced approach enabling the reconstruction of tissue defects by precisely bioprinting biologics under surgical settings. However, IOB has limited translational potential in its current form secondary to difficulty in establishing a rapidly functional, anastomosed vascular network. Micropuncture (MP) is an innovative microsurgical approach that overcomes this obstacle by creating targeted perforations in the host macrovasculature to stimulate angiogenesis, thereby facilitating microvascular ingrowth into adjacent bioprinted constructs. This study presents the first attempt of MP-induced vascularization of intraoperatively bioprinted constructs (10 mm × 15 mm × 3 mm). After precise optimization of bioink and cell compositions, IOB was performed in rat hindlimbs using rat aortic endothelial cell (RAOEC)-laden bioink to synergistically promote vascularization in conjugation with MP. The combination of MP and RAOECs demonstrated the highest values across all parameters such as a 1.8-fold vessel density increase, 2-fold increase in vessel length, a 2.5-fold increase in PECAM-1 expression, and a 4.2-fold increase in F4/80 expression on Day 40 compared to the bioink-only group. Additionally, perfusion was observed in bioprinted constructs, confirming functional microvascular anastomoses to the host. Taken together, the present study proposes an advanced pre-clinical strategy that integrates IOB for customized bioprinted platforms with MP to rapidly achieve effective in-situ vascularization.
术中生物打印(IOB)是一种先进的方法,能够在手术环境下通过精确地生物打印生物制剂来重建组织缺损。然而,由于难以建立快速发挥功能的吻合血管网络,IOB目前形式的转化潜力有限。微穿刺(MP)是一种创新的显微外科方法,通过在宿主大血管中制造有针对性的穿孔来刺激血管生成,从而促进微血管长入相邻的生物打印构建体,克服了这一障碍。本研究首次尝试通过MP诱导术中生物打印构建体(10毫米×15毫米×3毫米)的血管化。在对生物墨水和细胞成分进行精确优化后,使用负载大鼠主动脉内皮细胞(RAOEC)的生物墨水在大鼠后肢进行IOB,以与MP协同促进血管化。与仅使用生物墨水的组相比,在第40天时,MP和RAOEC的组合在所有参数上都显示出最高值,如血管密度增加1.8倍、血管长度增加2倍、PECAM-1表达增加2.5倍以及F4/80表达增加4.2倍。此外,在生物打印构建体中观察到灌注,证实了与宿主的功能性微血管吻合。综上所述,本研究提出了一种先进的临床前策略,即将用于定制生物打印平台的IOB与MP相结合,以快速实现有效的原位血管化。